| 000 | 01758 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250514215719.0 | ||
| 264 | 0 | _c20050621 | |
| 008 | 200506s 0 0 eng d | ||
| 022 | _a0021-9258 | ||
| 024 | 7 |
_a10.1074/jbc.M411890200 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFlatten, Karen | |
| 245 | 0 | 0 |
_aThe role of checkpoint kinase 1 in sensitivity to topoisomerase I poisons. _h[electronic resource] |
| 260 |
_bThe Journal of biological chemistry _cApr 2005 |
||
| 300 |
_a14349-55 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xmetabolism |
| 650 | 0 | 4 | _aAtaxia Telangiectasia Mutated Proteins |
| 650 | 0 | 4 |
_aCamptothecin _xanalogs & derivatives |
| 650 | 0 | 4 |
_aCell Cycle Proteins _xgenetics |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aCheckpoint Kinase 1 |
| 650 | 0 | 4 | _aCheckpoint Kinase 2 |
| 650 | 0 | 4 |
_aDNA Topoisomerases, Type I _xmetabolism |
| 650 | 0 | 4 | _aGene Deletion |
| 650 | 0 | 4 | _aGenes, cdc |
| 650 | 0 | 4 |
_aHSP90 Heat-Shock Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aProtein Kinases _xgenetics |
| 650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xgenetics |
| 650 | 0 | 4 |
_aRNA, Small Interfering _xgenetics |
| 650 | 0 | 4 | _aTopoisomerase I Inhibitors |
| 700 | 1 | _aDai, Nga T | |
| 700 | 1 | _aVroman, Benjamin T | |
| 700 | 1 | _aLoegering, David | |
| 700 | 1 | _aErlichman, Charles | |
| 700 | 1 | _aKarnitz, Larry M | |
| 700 | 1 | _aKaufmann, Scott H | |
| 773 | 0 |
_tThe Journal of biological chemistry _gvol. 280 _gno. 14 _gp. 14349-55 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1074/jbc.M411890200 _zAvailable from publisher's website |
| 999 |
_c15375618 _d15375618 |
||